Stockreport

TFF Pharmaceuticals Announces Pricing of $4.8 Million Public Offering

TFF Pharmaceuticals, Inc.  (TFFP) 
PDF FORT WORTH, Texas, April 29, 2024 (GLOBE NEWSWIRE) -- TFF Pharmaceuticals, Inc (Nasdaq: TFFP) (the “Company” or “TFF Pharmaceuticals”), a clinical-stage biopharmaceuti [Read more]